+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Pain Management Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024

  • ID: 4775623
  • Report
  • June 2019
  • Region: Global
  • 106 pages
  • IMARC Group
1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott Laboratories Inc.
  • Allergen Inc.
  • Eli Lilly & Company
  • F. Hoffmann La Roche Ltd.
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • MORE
The global pain management drugs market was worth US$ 38.9 Billion in 2018. Pain is a distressing feeling which can be caused due to various health issues such as osteoarthritis, chronic arthritis, diabetic neuropathy, multiple sclerosis and cancer. Pain mechanism is an intricate process, and there are several pain management drugs that provide relief by acting through various physiological functions. These medications are specific drugs that perform pharmacological actions on pain receptors and work against the discomfort-causing symptoms.

High prevalence of chronic pain diseases and increasing geriatric population are among the key factors driving the global pain management drugs market. In 2018, around 991 Million people across the globe were more than 60 years old. By 2024, we expect these figures to reach 1.18 Billion. With the prevalence of chronic pain being significantly higher in older adults, this represents a key factor driving the demand of pain management drugs. Additionally, the increasing number of hospitalization cases, a huge demand-supply gap for effective neuropathic pain management drugs, and application of innovative and advance therapies, are also catalyzing the growth of the market. Furthermore, increasing occurrence of chronic diseases such as cancer, arthritis, heart attacks and diabetes along with neurological issues are also boosting the global demand for these drugs. Moreover, factors such as rising healthcare expenditure, improving R&D, rising consumer awareness, and significant government support for improving healthcare services are also driving the growth of the market. Looking forward, the publisher expects the market to reach US$ 52.1 Billion by 2024, exhibiting a CAGR of around 5% during 2019-2024

Report Coverage:

Historical, Current and Future Market Trends

Market Breakup by Drug Class:
NSAIDs
Anesthetics
Anticonvulsants
Antimigraine Agents
Antidepressants
Opioids
Others

Market Breakup by Indication:
Musculoskeletal Pain
Surgical and Trauma Pain
Cancer Pain
Neuropathic Pain
Migraine Pain
Obstetrical Pain
Fibromyalgia Pain
Burn Pain
Dental/Facial Pain
Pediatric Pain
Others

Market Breakup by Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Market Breakup by Region:
North America
Europe
Asia Pacific
Middle East and Africa
Latin America

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Inc., Pfizer, Inc., Eli Lilly & Company, Endo Health Solutions, Inc., F. Hoffmann La Roche Ltd., Valeant Pharmaceuticals International Inc., Merck & Co. Inc., Allergen Inc., Novartis AG, Johnson & Johnson, GlaxoSmithKline Plc, Purdue Pharma L.P., etc.

Key Questions Answered in This Report:

How has the global pain management drugs market performed so far and how will it perform in the coming years?
What are the key regional markets in the global pain management drugs industry?
What is the breakup of the market based on the drug class?
What is the breakup of the market based on the indication?
What is the breakup of the market based on the distribution channel?
What are the various stages in the value chain of the global pain management drugs industry?
What are the key driving factors and challenges in the global pain management drugs industry?
What is the structure of the global pain management drugs industry and who are the key players?
What is the degree of competition in the global pain management drugs industry?
What are the profit margins in the global pain management drugs industry?
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories Inc.
  • Allergen Inc.
  • Eli Lilly & Company
  • F. Hoffmann La Roche Ltd.
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • MORE
1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Pain Management Drugs Market
5.1 Market Overview
5.2 Market Performance
5.3 Market Breakup by Drug Class
5.4 Market Breakup by Indication
5.5 Market Breakup by Distribution Channel
5.6 Market Breakup by Region
5.7 Market Forecast

6 Market Breakup by Drug Class
6.1 NSAIDs
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Anesthetics
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Anticonvulsants
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Antimigraine Agents
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Antidepressants
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Opioids
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 Others
6.7.1 Market Trends
6.7.2 Market Forecast

7 Market Breakup by Indication
7.1 Musculoskeletal Pain
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Surgical and Trauma Pain
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Cancer Pain
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Neuropathic Pain
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Migraine Pain
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Obstetrical Pain
7.6.1 Market Trends
7.6.2 Market Forecast
7.7 Fibromyalgia Pain
7.7.1 Market Trends
7.7.2 Market Forecast
7.8 Burn Pain
7.8.1 Market Trends
7.8.2 Market Forecast
7.9 Dental/Facial Pain
7.9.1 Market Trends
7.9.2 Market Forecast
7.10 Pediatric Pain
7.10.1 Market Trends
7.10.2 Market Forecast
7.11 Others
7.11.1 Market Trends
7.11.2 Market Forecast

8 Market Breakup by Distribution Channel
8.1 Hospital Pharmacies
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Retail Pharmacies
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Online Pharmacies
8.3.1 Market Trends
8.3.2 Market Forecast

9 Market Breakup by Region
9.1 North America
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Europe
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Asia Pacific
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Middle East and Africa
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Latin America
9.5.1 Market Trends
9.5.2 Market Forecast

10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis
13.1 Price Indicators
13.2 Price Structure
13.3 Margin Analysis

14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories, Inc.
14.3.2 Pfizer, Inc.
14.3.3 Eli Lilly & Company
14.3.4 Endo Health Solutions, Inc.
14.3.5 F. Hoffmann La Roche Ltd.
14.3.6 Valeant Pharmaceuticals International Inc.
14.3.7 Merck & Co. Inc.
14.3.8 Allergen Inc.
14.3.9 Novartis AG
14.3.10 Johnson & Johnson
14.3.11 GlaxoSmithKline Plc
14.3.12 Purdue Pharma L.P.
Note: Product cover images may vary from those shown
3 of 4
  • Abbott Laboratories Inc.
  • Pfizer Inc.
  • Eli Lilly & Company
  • Endo Health Solutions Inc.
  • F. Hoffmann La Roche Ltd.
  • Valeant Pharmaceuticals International Inc.
  • Merck & Co. Inc.
  • Allergen Inc.
  • Novartis AG
  • Johnson & Johnson
  • GlaxoSmithKline Plc
  • Purdue Pharma L.P.
Note: Product cover images may vary from those shown
4 of 4

Loading
LOADING...

Adroll
adroll